title: Treatment Profile And Insulin Dose as a Factor Impacting Glycaemia Control Among Premix Insulin Users with T2DM in China.
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, China.
authors.forename: L
authors.initials: L
authors.lastname: Gu
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, China.
authors.forename: B H
authors.initials: BH
authors.lastname: Curtis
authors.affiliation: Eli Lilly and Company, Carmel, IN, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Babineaux